EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine

E Reijnders, A van der Laarse, J W Jukema, C M Cobbaert

Frontiers in Cardiovascular Medicine · 16.10.2023 · 10

DOI: 10.3389/fcvm.2023.1264319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.10.2023. Verfasst von E Reijnders und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, Netherlands. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As time has come to translate trial results into individualized medical diagnosis and therapy, we analyzed how to minimize residual risk of cardiovascular disease (CVD) by reviewing papers on “residual cardiovascular disease risk”. During this review process we found 989 papers that started off with residual CVD risk after initiating statin therapy, continued with papers on residual CVD risk after initiating therapy to increase high-density lipoprotein-cholesterol (HDL-C), followed by papers on residual CVD risk after initiating therapy to decrease triglyceride (TG) levels. Later on, papers dealing with elevated levels of lipoprotein remnants and lipoprotein(a) [Lp(a)] reported new risk factors of residual CVD risk. And as new risk factors are being discovered and new therapies are being tested, residual CVD risk will be reduced further. As we move from CVD risk reduction to improvement of patient management, a paradigm shift from a reductionistic approach towards a holistic approach is required. To that purpose, a personalized treatment dependent on the individual’s CVD risk factors including lipid profile abnormalities should be configured, along the line of P5 medicine for each individual patient, i.e., with Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive approaches.

Schlagwörter

Stichwörter der Autor:innen

p5 medicinepersonalized medicineprecision medicineresidual cardiovascular riskresidual inflammatory riskresidual thrombotic risk

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.
  • Netherlands Heart Institute, Utrecht, Netherlands.

Zitieren

APA

Reijnders, E., van der Laarse, A., Jukema, J. W., & Cobbaert, C. M. (2023). High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1264319

Vancouver

Reijnders E, van der Laarse A, Jukema JW, Cobbaert CM. High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1264319

BibTeX
@article{Reijnders2023,
  author = {Reijnders, E and van der Laarse, A and Jukema, J W and Cobbaert, C M},
  title = {High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1264319}
}
Kostenlos starten →